SOMERSET, N.J., Aug. 10, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced today that Bill Korn, Chief Strategy Officer and Larry Steenvoorden, Chief Financial Officer will be participating in the Sidoti Virtual Investor Conference, taking place on Wednesday, August 16, 2023 and Thursday, August 17, 2023, including a presentation on Thursday, August 17, 2023 at 10:45 a.m. EDT. They will also be available for one-on-one meetings to discuss CareCloud’s strategy and business performance both days.
To arrange a meeting with Bill and Larry, investors can contact Bridget Forde at CareCloudIR@westwicke.com. To view the replay of this presentation, please visit CareCloud’s investor relations site at ir.carecloud.com/events, and click on Sidoti Virtual Investor Conference.
About CareCloud
CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at www.carecloud.com.
Follow CareCloud on LinkedIn, Twitter and Facebook.
For additional information, please visit our website at www.carecloud.com. To view CareCloud’s latest investor presentations, read recent press releases, and listen to interviews with management, please visit ir.carecloud.com.
Company Contact:
Bill Korn
Chief Strategy Officer
CareCloud, Inc.
bkorn@carecloud.com
Investor Contact:
Asher Dewhurst
ICR Westwicke
CareCloudIR@westwicke.com
Media Inquiries:
Alexis Feinberg
ICR Westwicke
CareCloudPR@westwicke.com
| Last Trade: | US$2.39 |
| Daily Change: | -0.08 -3.24 |
| Daily Volume: | 200,112 |
| Market Cap: | US$101.140M |
July 17, 2025 June 02, 2025 May 06, 2025 April 07, 2025 April 02, 2025 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
